Diabetic neuroosteoarthropathy: an interdisciplinary expert consensus

OBJECTIVE. To analyze and describe existing methods for the diagnosis and treatment of diabetic neuroosteoarthropathy.

MATERIALS AND METHODS. A search and analysis of clinical trials, meta-analyses, systematic reviews and clinical guidelines on the diagnosis and treatment of Charcot neuroarthropathy was conducted. The literature search was carried out across the MEDLINE, ELibrary, PubMed, Web of Science, Google Scholar, and Clinical Key databases. The search covered a 20-year period; publications of historical significance were also included.

RESULTS. A total of 165 publications were incorporated into this review. The paper outlines key features of the clinical presentation and course of diabetic neuroosteoarthropathy, and summarizes current scientific understanding of its etiology, classification, diagnostic criteria and treatment options.

CONCLUSION. Implementation of the proposed algorithms will help to objectify the diagnosis and improve the quality of medical care provided to patients with Charcot neuroarthropathy.

1. Johnsen RG, Armstrong DG, et al. The Charcot foot in diabetes. J Am Podiatr Med Assoc. 2011;101(5):437-446. doi: https://doi.org/10.7547/1010437

2. Dedov II, Shestakova MV, Sukhareva OY, et al. Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Sukhareva O. Yu. 12th Edition. Diabetes mellitus. 2025;28(5S):1-175. (In Russ.) doi: https://doi.org/10.14341/DM20255S

3. Приказ Министерства здравоохранения РФ от 28 февраля 2019 г. N 103н "Об утверждении порядка и сроков разработки клинических рекомендаций, их пересмотра, типовой формы клинических рекомендаций и требований к их структуре, составу и научной обоснованности, включаемой в клинические рекомендации информации". Приложение N 2 к Требованиям к структуре клинических рекомендаций, составу и научной обоснованности, включаемой в клинические рекомендации информации, утвержденным приказом Министерства здравоохранения Российской Федерации от 28 февраля 2019 г. №103н (с изменениями от 23 июня 2020 г.)

4. Pinzur MS. Current concepts review: Charcot arthropathy of the foot and ankle. Foot Ankle Int. 2007;28(8):952-959. doi: https://doi.org/10.3113/FAI.2007.0952

5. Rabinovich A. Conservative treatment can be efficacious in treatment of Charcot arthropathy. Orthopaedics Today. 2010;11:56-58

6. Strakhova GY, Kakubava MR. The clinical experience of the Diabetic Foot Centre for treatment of Charcot Neuro-Arthropathy. Infektsii v Khirurgii. 2022;20(2):110–113. (In Russ.)

7. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796-800. doi: https://doi.org/10.2337/diacare.23.6.796

8. McEwen LN, Ylitalo KR, Munson M, Herman WH, Wrobel JS. Foot Complications and Mortality: Results from Translating Research Into Action for Diabetes (TRIAD). J Am Podiatr Med Assoc. 2016;106(1):7-14. doi: https://doi.org/10.7547/14-115

9. Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008;121(11):1008-1014. doi: https://doi.org/10.1016/j.amjmed.2008.06.038

10. Galstyan GR, Vikulova OK, Isakov MA, et al. Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013–2016). Diabetes mellitus. 2018;21(3):170-177. doi: https://doi.org/10.14341/DM9688

11. Bregovskiy VB, Karpova IA. Analysis of specialized care for patients with diabetic foot syndrome in St. Petersburg for 2010–2021. Diabetes mellitus. 2022;25(5):477-484. (In Russ.) doi: https://doi.org/10.14341/DM12914

12. Schon LC, Easley ME, Weinfeld SB. Charcot neuroarthropathy of the foot and ankle. Clin Orthop Relat Res. 1998;(349):116-131. doi: https://doi.org/10.1097/00003086-199804000-00015

13. Kalandiya MM, Tokmakova AY, Galstyan GR. The role of glycation end products in the development and progression of diabetic neuroarthropathy. Problems of Endocrinology. 2021;67(3):4-9. (In Russ.) doi: https://doi.org/10.14341/probl12778

14. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy. Int J Immunopathol Pharmacol. 2010;23(4):997-1003. doi: https://doi.org/10.1177/039463201002300404

15. Couppé C, Svensson RB, Kongsgaard M, et al. Human Achilles tendon glycation and function in diabetes. J Appl Physiol. 2016;120(2):130-137. doi: https://doi.org/10.1152/japplphysiol.00547.2015

16. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am. 1998;80(3):365-369. doi: https://doi.org/10.2106/00004623-199803000-00009

17. Fernando M, Crowther R, Lazzarini P, et al. Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and metaanalysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech (Bristol). 2013;28(8):831-845. doi: https://doi.org/10.1016/j.clinbiomech.2013.08.004

18. Baker N, Green A, Krishnan S, et al. Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. 2007;30(12):3077-3079. doi: https://doi.org/10.2337/dc07-10638

19. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366(9502):2058-2061. doi: https://doi.org/10.1016/S0140-6736(05)67029-8

20. Greco T, Mascio A, Comisi C, et al. RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and ClinicalTherapeutic Implications. Int J Mol Sci. 2023;24(3):3014. doi: https://doi.org/10.3390/ijms24033014

21. Petrova NL, Petrov PK, Edmonds ME, Shanahan CM. Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy. J Diabetes Res. 2015;2015:917945. doi: https://doi.org/10.1155/2015/917945

22. Yaroslavtseva МV, Ul'yanova IN, Galstyan GR. Sistema osteoprotegerin (OPG) -ligand retseptoraaktivatora yadernogo faktora kappa-V (RANKL) pri diabeticheskoy neyroosteoartropatii i obliteriruyushchem ateroskleroze arteriy nizhnikh konechnostey. Diabetes mellitus. 2007;10(2):24-27. (In Russ.) doi: https://doi.org/10.14341/2072-0351-5792

23. Game FL, Catlow R, Jones GR, et al. Audit of acute Charcot's disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32-35. doi: https://doi.org/10.1007/s00125-011-2354-7

24. Milne TE, Rogers JR, Kinnear EM, et al. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review. J Foot Ankle Res. 2013;6(1):30. doi: https://doi.org/10.1186/1757-1146-6-30

25. Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46-63. doi: https://doi.org/10.1177/107110070502600109

26. Sämann A, Pofahl S, Lehmann T, et al. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes. 2012;120(6):335-339. doi: https://doi.org/10.1055/s-0031-1299705

27. Eichenholtz S. Charcot joints. Springfield (IL): Charles C. Thomas; 1966

28. Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92(4):210-220. doi: https://doi.org/10.7547/87507315-92-4-210

29. Chantelau EA, Grützner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144:w13948. doi: https://doi.org/10.4414/smw.2014.13948

30. Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging- -a review of 71 cases. Swiss Med Wkly. 2013;143:w13831. doi: https://doi.org/10.4414/smw.2013.13831

31. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: The Charcot foot. In: The High Risk Foot in Diabetes Mellitus. Frykberg RG, editor. New York: Churchill Livingstone; 1991. p. 325-333

32. Gratwohl V, Jentzsch T, Schöni M, et al. Long-term follow-up of conservative treatment of Charcot feet. Arch Orthop Trauma Surg. 2022;142(10):2553-2566. doi: https://doi.org/10.1007/s00402-021-03881-5

33. Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43-vi. doi: https://doi.org/10.1016/j.cpm.2007.10.006

34. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14(5):357-363. doi: https://doi.org/10.1002/(SICI)1096-9136(199705)14:5<357::AIDDIA341>3.0.CO;2-8

35. Wukich DK, Raspovic KM, Suder NC. Prevalence of Peripheral Arterial Disease in Patients With Diabetic Charcot Neuroarthropathy. J Foot Ankle Surg. 2016;55:727–731. doi: https://doi.org/10.1053/j.jfas.2016.01.051

36. Sohn MW, Stuck RM, Pinzur M, et al. Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care. 2010;33(1):98-100. doi: https://doi.org/10.2337/dc09-1497

37. Christensen TM, Gade-Rasmussen B, Pedersen LW, et al. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker. J Diabetes Complications. 2012;26(5):430-434. doi: https://doi.org/10.1016/j.jdiacomp.2012.05.006

38. Osterhoff G, Böni T, Berli M. Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment. Foot Ankle Int. 2013;34(3):359–364. doi: https://doi.org/10.1177/1071100712464957

39. Dhawan V, Spratt KF, Pinzur MS, et al. Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int. 2005;26(9):717-31. doi: https://doi.org/10.1177/107110070502600910

40. Molines L, Darmon P, Raccah D. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;36(4):251-255. doi: https://doi.org/10.1016/j.diabet.2010.04.002

41. Wukich DK, Schaper NC, Gooday C, et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes Metab Res Rev. 2024;40(3):e3646. doi: https://doi.org/10.1002/dmrr.3646

42. Raspovic KM, Schaper NC, Gooday C, et al. Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2024;40(3):e3653. doi: https://doi.org/10.1002/dmrr.3653

43. Galstyan GR, Kaminarskaya YA. The pathogenesis of Charcot osteoarthropathy: the role of the peripheral nervous system. Endocrine Surgery. 2014;8(4):5-14. (In Russ.) doi: https://doi.org/10.14341/serg201445-14

44. Jeffcoate W, Game F. The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm. Diabetes Care. 2022;45(7):1691-1697. doi: https://doi.org/10.2337/dc21-2508

45. Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy-current standards. Diabetes Metab Res Rev. 2008;24 Suppl 1:S58-S61. doi: https://doi.org/10.1002/dmrr.846

46. Bregovskiy VB. Radiology diagnostics of the diabetic Charcot neuroarthropathy. Translational Medicine. 2021;8(1):12-18. (In Russ.) doi: https://doi.org/10.18705/2311-4495-2021-8-1-12-18

47. Jones PJ, Davies MJ, Webb D, Berrington R, Frykberg RG. Contralateral foot temperature monitoring during Charcot immobilisation: A systematic review. Diabetes Metab Res Rev. 2023;39(4):e3619. doi: https://doi.org/10.1002/dmrr.3619

48. Moura-Neto A, Fernandes TD, Zantut-Wittmann DE, et al. Charcot foot: skin temperature as a good clinical parameter for predicting disease outcome. Diabetes Res Clin Pract. 2012;96(2):e11-e14. doi: https://doi.org/10.1016/j.diabres.2011.12.029

49. Dallimore SM, Puli N, Kim D, Kaminski MR. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy. J Foot Ankle Res. 2020;13(1):56. doi: https://doi.org/10.1186/s13047-020-00421-z

50. Fletcher T, Whittam A, Simpson R, Machin G. Comparison of non-contact infrared skin thermometers. J Med Eng Technol. 2018;42(2):65-71. doi: https://doi.org/10.1080/03091902.2017.1409818

51. Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009;23(6):409-426. doi: https://doi.org/10.1016/j.jdiacomp.2008.09.004

52. Andersen LB, Dipreta J. Charcot of the calcaneus. Foot Ankle Clin. 2006;11(4):825-835. doi: https://doi.org/10.1016/j.fcl.2006.06.010

53. Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg. 2008;25(2):263-274. doi: https://doi.org/10.1016/j.cpm.2008.01.002

54. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129. doi: https://doi.org/10.2337/dc11-0844

55. Gooday C, Game F, Woodburn J, et al. A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM). J Foot Ankle Res. 2023;16(1):2. doi: https://doi.org/10.1186/s13047-023-00601-7

56. Schlossbauer T, Mioc T, Sommerey S, Kessler SB, Reiser MF, Pfeifer KJ. Magnetic resonance imaging in early stage charcot arthropathy: correlation of imaging findings and clinical symptoms. Eur J Med Res. 2008;13(9):409-414.

57. Zampa V, Bargellini I, Rizzo L, et al. Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol. 2011;40(8):991-999. doi: https://doi.org/10.1007/s00256-010-1092-0

58. Gooday C, Hardeman W, Poland F, Woodburn J, Dhatariya K. Controversies in the management of active Charcot neuroarthropathy. Ther Adv Endocrinol Metab. 2023;14:20420188231160406. doi: https://doi.org/10.1177/20420188231160406

59. Martín Noguerol T, Luna Alcalá A, Beltrán LS, Gómez Cabrera M, Broncano Cabrero J, Vilanova JC. Advanced MR Imaging Techniques for Differentiation of Neuropathic Arthropathy and Osteomyelitis in the Diabetic Foot. Radiographics. 2017;37(4):1161-1180. doi: https://doi.org/10.1148/rg.2017160101

60. Rosskopf AB, Loupatatzis C, Pfirrmann CWA, Böni T, Berli MC. The Charcot foot: a pictorial review. Insights Imaging. 2019;10(1):77. doi: https://doi.org/10.1186/s13244-019-0768-9

61. Ertugrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle. 2013;4:10.3402/dfa.v4i0.21855. doi: https://doi.org/10.3402/dfa.v4i0.21855

62. Tan PL, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol. 2007;80(959):939-948. doi: https://doi.org/10.1259/bjr/30036666

63. Dvoryanchikov YV, Tokmakova AY, Galstyan GR, et al. Differential diagnosis of diabetic neuroosteoarthropathy and osteomyelitis using medical imaging techniques. Endocrine Surgery. 2024;18(2):30-38. (In Russ.) doi: https://doi.org/10.14341/serg12842

64. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007;28(6):465-472. doi: https://doi.org/10.1097/MNM.0b013e328174447f

65. Mautone M, Naidoo P. What the radiologist needs to know about Charcot foot. J Med Imaging Radiat Oncol. 2015;59(4):395-402. doi: https://doi.org/10.1111/1754-9485.12325

66. Campanaro NR, Gurr JM, Murray RJ. Percutaneous bone biopsy to distinguish osteomyelitis from charcot osteoarthropathy: two case reports. Foot Ankle Int. 2009;30(12):1219-1224. doi: https://doi.org/10.3113/FAI.2009.1219

67. Johnsen B. Acute Charcot's arthropathy: a difficult diagnosis. JAAPA. 2007;20(7):22-26. doi: https://doi.org/10.1097/01720610-200707000-00005

68. Lavery LA, Crisologo PA, La Fontaine J, Bhavan K, Oz OK, Davis KE. Are We Misdiagnosing Diabetic Foot Osteomyelitis? Is the Gold Standard Gold?. J Foot Ankle Surg. 2019;58(4):713-716. doi: https://doi.org/10.1053/j.jfas.2018.12.010

69. Leung HB, Ho YC, Wong WC. Charcot foot in a Hong Kong Chinese diabetic population. Hong Kong Med J. 2009;15(3):191-195

70. National Evidence-Based Guideline on Prevention. Identification and Management of Foot Complications in Diabetes (Part of the Guidelines on Management of Type 2 Diabetes). Melbourne; 2011

71. Sinacore DR, Hastings MK, Bohnert KL, et al. Inflammatory osteolysis in diabetic neuropathic (Charcot) arthropathies of the foot. Phys Ther. 2008;88(11):1399-1407. doi: https://doi.org/10.2522/ptj.20080025

72. Ziegler D, Tesfaye S, Spallone V, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063. doi: https://doi.org/10.1016/j.diabres.2021.109063

73. Baglioni P, Malik M, Okosieme OE. Acute Charcot foot. BMJ. 2012;344:e1397. doi: https://doi.org/10.1136/bmj.e1397

74. Petrova NL, Moniz C, Elias DA, Buxton-Thomas M, Bates M, Edmonds ME. Is there a systemic inflammatory response in the acute charcot foot? Diabetes Care. 2007;30(4):997-998. doi: https://doi.org/10.2337/dc06-2168

75. Svendsen OL, Rabe OC, Winther-Jensen M, Allin KH. How Common Is the Rare Charcot Foot in Patients With Diabetes? Diabetes Care. 2021;44(4):e62-e63. doi: https://doi.org/10.2337/dc20-2590

76. Tsatsaris G, Rajamand Ekberg N, Fall T, Catrina SB. Risk factors for Charcot foot development in individuals with diabetes mellitus. Diabetologia. 2024;67(12):2702-2710. doi: https://doi.org/10.1007/s00125-024-06271-9

77. Hjelm LR. Diabetes Mellitus: An Overview in Relationship to Charcot Neuroarthropathy. Clin Podiatr Med Surg. 2022;39(4):535-542. doi: https://doi.org/10.1016/j.cpm.2022.05.001

78. Rastogi A, Bhansali A, Jude EB. Efficacy of medical treatment for Charcot neuroarthropathy: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2021;58(6):687-696. doi: https://doi.org/10.1007/s00592-020-01664-9

79. Demina AG, Bregovskii VB, Karpova IA. Charcot diabetic neuroosteoartropathy: review of pathology and outpatient care experience. Consilium Medicum. 2020;22(4):55–60. (In Russ.) doi: https://doi.org/10.26442/20751753.2020.4.200130

80. Udovichenko OV, Bublik EV, Maksimova NV, et al. Effectiveness of immobilizing off-loading dressings (Total Contact Cast): a review of foreign randomized clinical trials and original data. Diabetes mellitus. 2010;13(2):50–55. (In Russ.) doi: https://doi.org/10.14341/2072-0351-5674

81. Wukich DK, Sung W, Wipf SA, Armstrong DG. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28(2):195-198. doi: https://doi.org/10.1111/j.1464-5491.2010.03141.x

82. Verity S, Sochocki M, Embil JM, Trepman E. Treatment of Charcot foot and ankle with a prefabricated removable walker brace and custom insole. Foot Ankle Surg. 2008;14(1):26-31. doi: https://doi.org/10.1016/j.fas.2007.10.002

83. Hunter A. The treatment of Charcot neuroarthropathy with an Aircast Pneumatic Walker: a case study. Podiatry Now. 2006;9(7):44-47

84. Bus SA, Armstrong DG, Gooday C, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3274. doi: https://doi.org/10.1002/dmrr.3274

85. Kaminarskaya YA. Diabetic neuroosteoarthropathy: the modern approaches for diagnosis and immobilization period determination (review). Endocrine Surgery. 2015;9(2):15-23. (In Russ.) doi: https://doi.org/10.14341/serg2015215-23

86. Yammine K, Otayek J, Assi C. Evidence-based conservative limb preserving surgery for the diabetic foot complications: A systematic review of systematic reviews. Foot Ankle Surg. 2022;28(6):670-679. doi: https://doi.org/10.1016/j.fas.2021.08.006

87. Nilsen FA, Molund M, Hvaal KH. High Incidence of Recurrent Ulceration and Major Amputations Associated With Charcot Foot. J Foot Ankle Surg. 2018;57(2):301-304. doi: https://doi.org/10.1053/j.jfas.2017.10.008

88. Schneekloth BJ, Lowery NJ, Wukich DK. Charcot Neuroarthropathy in Patients With Diabetes: An Updated Systematic Review of Surgical Management. J Foot Ankle Surg. 2016;55(3):586-590. doi: https://doi.org/10.1053/j.jfas.2015.12.001

89. Shazadeh Safavi P, Jupiter DC, Panchbhavi V. A Systematic Review of Current Surgical Interventions for Charcot Neuroarthropathy of the Midfoot. J Foot Ankle Surg. 2017;56(6):1249-1252. doi: https://doi.org/10.1053/j.jfas.2017.06.011

90. Ha J, Hester T, Foley R, et al. Charcot foot reconstruction outcomes: A systematic review. J Clin Orthop Trauma. 2020;11(3):357-368. doi: https://doi.org/10.1016/j.jcot.2020.03.025

91. Ong SL, Bajuri MY, Mazli N. Outcome of Surgical Fixation for Midfoot Charcot Neuroarthropathy - A Systematic Review. Malays Orthop J. 2023;17(1):27-33. doi: https://doi.org/10.5704/MOJ.2303.004

92. Palena LM, Brocco E, Manzi M. Critical limb ischemia in association with Charcot neuroarthropathy: complex endovascular therapy for limb salvage. Cardiovasc Intervent Radiol. 2014;37(1):257-261. doi: https://doi.org/10.1007/s00270-013-0642-y

93. Osnach SA, Vinogradov VA, Eroshenko AV, et al. Revascularization and subsequent orthopedic reconstruction of the foot for diabetic Charcot neuroosteoarthropathy. Clinical and Experimental Surgery. Petrovsky Journal. 2024;12(2):81–92. (In Russ.) doi: https://doi.org/10.33029/2308-1198-2024-12-2-81-92

94. Cates NK, Elmarsafi T, Bunka TJ, et al. Peripheral Vascular Disease Diagnostic Related Outcomes in Diabetic Charcot Reconstruction. J Foot Ankle Surg. 2019;58(6):1058-1063. doi: https://doi.org/10.1053/j.jfas.2019.06.002

95. Elmarsafi T, Anghel EL, Sinkin J, et al. Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction. J Foot Ankle Surg. 2019;58(2):295-300. doi: https://doi.org/10.1053/j.jfas.2018.08.059

96. Orioli L, Hammer F, Vande Berg B, Putineanu D, Maiter D, Vandeleene B. Prevalence, Characteristics, and Prognosis of Peripheral Arterial Disease in Patients With Diabetic Charcot Foot. J Foot Ankle Surg. 2021;60(6):1158-1163. doi: https://doi.org/10.1053/j.jfas.2021.04.021

97. Waibel FW, Schöni M, Kronberger L, et al. Treatment Failures in Diabetic Foot Osteomyelitis Associated with Concomitant Charcot Arthropathy: The Role of Underlying Arteriopathy. Int J Infect Dis. 2022;114:15-20. doi: https://doi.org/10.1016/j.ijid.2021.10.036

98. Al Omar H, Lahoti O, Edmonds M, Kavarthapu V. Ischaemic Charcot Midfoot Reconstruction Combined with Lateral Tibial Cortex Transverse Transport: Case Report. Strategies Trauma Limb Reconstr. 2025;20(1):50-55. doi: https://doi.org/10.5005/jp-journals-10080-1637

99. Imaoka S, Kudou G, Minata S, Furukawa M, Higashi T. Changes in physical function and ambulatory state after Achilles tendon lengthening for diabetic foot ulcers. J Phys Ther Sci. 2023;35(1):51-54. doi: https://doi.org/10.1589/jpts.35.51

100. Lavery LA, Armstrong DG, Boulton AJ; Diabetex Research Group. Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. J Am Podiatr Med Assoc. 2002;92(9):479-482. doi: https://doi.org/10.7547/87507315-92-9-479

101. Ramanujam CL, Zgonis T. Surgical Correction of the Achilles Tendon for Diabetic Foot Ulcerations and Charcot Neuroarthropathy. Clin Podiatr Med Surg. 2017;34(2):275-280. doi: https://doi.org/10.1016/j.cpm.2016.10.013

102. Capobianco CM, Stapleton JJ, Zgonis T. The role of an extended medial column arthrodesis for Charcot midfoot neuroarthropathy. Diabet Foot Ankle. 2010;1:10.3402/dfa.v1i0.5282. doi: https://doi.org/10.3402/dfa.v1i0.5282

103. Khan O, Kavarthapu M, Edmonds M, Kavarthapu V. Surgical management of Charcot foot - The advancements over the past decade. J Clin Orthop Trauma. 2023;47:102317. doi: https://doi.org/10.1016/j.jcot.2023.102317

104. Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23(2):130-134. doi: https://doi.org/10.1177/107110070202300209

105. Pinzur MS, Gil J, Belmares J. Treatment of osteomyelitis in charcot foot with single-stage resection of infection, correction of deformity, and maintenance with ring fixation. Foot Ankle Int. 2012;33(12):1069-1074. doi: https://doi.org/10.3113/FAI.2012.1069

106. Hasan K, Metikala S, Vallem MMR. Salvage of Hindfoot Charcot with Osteomyelitis and Ulceration: A Case Report. Medicines (Basel). 2022;9(12):61. doi: https://doi.org/10.3390/medicines9120061

107. Kavarthapu V, Budair B. Two-stage reconstruction of infected Charcot foot using internal fixation : a promising functional limb salvage technique. Bone Joint J. 2021;103-B(10):1611-1618. doi: https://doi.org/10.1302/0301-620X.103B10.BJJ-2021-0339.R2

108. Osnach SА, Obolensky VN, Protsko VG, et al. Method of two-stage treatment of total and subtotal defects of the foot in Charcot neuroosteoarthropathy. Genij Ortopedii. 2022;28(4):523-531. (In Russ.) doi: https://doi.org/10.18019/1028-4427-2022-28-4-523-531

109. Capobianco CM, Zgonis T. Abductor hallucis muscle flap and staged medial column arthrodesis for the chronic ulcerated charcot foot with concomitant osteomyelitis. Foot Ankle Spec. 2010;3(5):269-273. doi: https://doi.org/10.1177/1938640010382038

110. Ramanujam CL, Stapleton JJ, Zgonis T. Negative-pressure wound therapy in the management of diabetic Charcot foot and ankle wounds. Diabet Foot Ankle. 2013;4:10.3402/dfa.v4i0.20878. doi: https://doi.org/10.3402/dfa.v4i0.20878

111. Abbate OA, Lakhiani C, Janhofer DE, et al. Long Term Follow Up of a Vascularized Osteocutaneous Free Flap for Reconstruction in Charcot Neuroarthropathy: A Case Report. Ann Plast Surg. 2019;82(2):180-183. doi: https://doi.org/10.1097/SAP.0000000000001670

112. Short DJ, Zgonis T. Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle. Clin Podiatr Med Surg. 2017;34(3):381-387. doi: https://doi.org/10.1016/j.cpm.2017.02.008

113. Mak MF, Stern R, Assal M. Masquelet Technique for Midfoot Reconstruction Following Osteomyelitis in Charcot Diabetic Neuropathy: A Case Report. JBJS Case Connect. 2015;5(2):e28. doi: https://doi.org/10.2106/JBJS.CC.N.00112

114. Bajuri MY, Ong SL, Das S, Mohamed IN. Charcot Neuroarthropathy: Current Surgical Management and Update. A Systematic Review. Front Surg. 2022;9:820826. doi: https://doi.org/10.3389/fsurg.2022.820826

115. Herbst SA. External fixation of Charcot arthropathy. Foot Ankle Clin. 2004;9(3):595-609. doi: https://doi.org/10.1016/j.fcl.2004.05.010

116. Abar B, Kwon N, Allen NB, et al. Outcomes of Surgical Reconstruction Using Custom 3D-Printed Porous Titanium Implants for Critical-Sized Bone Defects of the Foot and Ankle. Foot Ankle Int. 2022;43(6):750-761. doi: https://doi.org/10.1177/10711007221077113

117. Kim M, Mann T, Kelly C, et al. Outcomes of Charcot Arthropathy Limb Salvage with Patient-Specific 3D-Printed Cage and Dynamic Hindfoot Fusion Nail Combination Fixation. Research Square [Internet]. 2024 [cited 2025 Dec 15]. Available from: https://www.researchsquare.com/article/rs-4096092/v1. doi: https://doi.org/10.21203/rs.3.rs-4096092/v1

118. Wang G, Lin J, Zhang H, Pei Y, Zhu L, Xu Q. Three-dimension correction of Charcot ankle deformity with a titanium implant. Comput Assist Surg (Abingdon). 2021;26(1):15-21. doi: https://doi.org/10.1080/24699322.2021.1887356

119. Osnach SA, Protsko VG, Obolensky VN, et al. Management of a total defect of the talus with a customized 3D-implant made of porous titanium for Charcot neuroosteoarthropathy in a patient with neurosyphilis: a case report. Genij Ortopedii. 2025;31(1):66-73. (In Russ.) doi: https://doi.org/10.18019/1028-4427-2025-31-1-66-73

120. Kavarthapu V, Haldar A. РFord Reconstruction of unstable ankle charcot deformity using a 3-D printed titanium porous block and hindfoot nail - A case report. Foot (Edinb). 2024;60:102116. doi: https://doi.org/10.1016/j.foot.2024.102116

121. Siddiqui NA, Millonig KJ, Mayer BE, Fink JN, McClure PK, Bibbo C. Increased Arthrodesis Rates in Charcot Neuroarthropathy Utilizing Distal Tibial Distraction Osteogenesis Principles. Foot Ankle Spec. 2022;15(4):394-408. doi: https://doi.org/10.1177/19386400221087822

122. Millonig KJ, Siddiqui NA. Tibial Lengthening and Intramedullary Nail Fixation for Hindfoot Charcot Neuroarthropathy. Clin Podiatr Med Surg. 2022;39(4):659-673. doi: https://doi.org/10.1016/j.cpm.2022.05.011

123. Schade VL, Andersen CA. A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle. Diabet Foot Ankle. 2015;6:26627. doi: https://doi.org/10.3402/dfa.v6.26627

124. Osnach SA, Protsko VG, Obolensky VN, et al. Comparison of orthopaedic reconstruction of diabetic Charcot foot Eichenholtz stages 1-2 and conservative treatment. Genij Ortopedii. 2023;29(3):244-252. (In Russ.) doi: https://doi.org/10.18019/1028-4427-2023-29-3-244-252

125. Grant WP, Garcia-Lavin S, Sabo R. Beaming the columns for Charcot diabetic foot reconstruction: a retrospective analysis. J Foot Ankle Surg. 2011;50(2):182-189. doi: https://doi.org/10.1053/j.jfas.2010.12.002

126. Mateen S, Thomas MA, Jappar A, et al. Progression to Hindfoot Charcot Neuroarthropathy After Midfoot Charcot Correction in Patients With and Without Subtalar Joint Arthrodesis. J Foot Ankle Surg. 2023;62(4):731-736. doi: https://doi.org/10.1053/j.jfas.2023.03.004

127. Manchanda K, Wallace SB, Ahn J, et al. Charcot Midfoot Reconstruction: Does Subtalar Arthrodesis or Medial Column Fixation Improve Outcomes? J Foot Ankle Surg. 2020;59(6):1219-1223. doi: https://doi.org/10.1053/j.jfas.2020.07.001

128. Cullen BD, Weinraub GM, Van Gompel G. Early results with use of the midfoot fusion bolt in Charcot arthropathy. J Foot Ankle Surg. 2013;52(2):235-238. doi: https://doi.org/10.1053/j.jfas.2012.12.003

129. Dos Santos-Vaquinhas A, Parra G, Martínez P, Sobrón B, CuervasMons M. Beaming in the Charcot foot: A case series with 12-month minimum follow-up. Foot (Edinb). 2021;47:101814. doi: https://doi.org/10.1016/j.foot.2021.101814

130. Frøkjær J. Surgical treatment of midfoot charcot neuroarthropathy review of literature and our results after superconstruct reconstruction of midfoot charcot neuroarthropathy. J Clin Orthop Trauma. 2021;17:59-64. doi: https://doi.org/10.1016/j.jcot.2021.02.003

131. Mehlhorn AT, Walther M, Iblher N, Südkamp NP, Schmal H. Complication assessment and prevention strategies using midfoot fusion bolt for medial column stabilization in Charcot's osteoarthropathy. Foot (Edinb). 2016;29:36-41. doi: https://doi.org/10.1016/j.foot.2016.10.005

132. Wirth SH, Viehöfer AF, Tondelli T, et al. Mid-term walking ability after Charcot foot reconstruction using the Ilizarov ring fixator. Arch Orthop Trauma Surg. 2020;140(12):1909-1917. doi: https://doi.org/10.1007/s00402-020-03407-5

133. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in diabetic charcot feet. Clin Orthop Relat Res. 1993;(296):21-26

134. Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000;39(5):291-300. doi: https://doi.org/10.1016/s1067-2516(00)80045-9

135. Mitish VA, Galstyan GR, Doronina LP, et al. Vozmozhnosti khirurgicheskogo lecheniya stopy Sharko, oslozhnennoy gnoynoy infektsiey. Endocrine Surgery. 2008;2(2):28-31. (In Russ.) doi: https://doi.org/10.14341/2306-3513-2008-2-28-31

136. Mitish VA, Galstyan GR, Doronina LP, et al. Surgical treatment of Charcot foot with purulent infection. Diabetes mellitus. 2009;12(1):59-63. (In Russ.) doi: https://doi.org/10.14341/2072-0351-5425

137. Mitish VA, Paskhalova YS, Garyaeva VV, et al. The successful complex treatment diabetic neuroosteoarthropathy of the middle part of the foot in the stage of purulent complications. Wounds and wound infections. The Prof. B. M. Kostuchenok Journal. 2017;4(4):28–37. doi: https://doi.org/10.25199/2408-9613-2017-4-4-28-37

138. Kalandiya MM, Doronina LP, Mitish VA, et al. Long-term results of corrective surgical interventions in patients with diabetic midfoot neuroosteoarthropathy. Diabetes mellitus. 2023;26(5):464-472. (In Russ.) doi: https://doi.org/10.14341/DM13000

139. Laurinaviciene R, Kirketerp-Moeller K, Holstein PE. Exostectomy for chronic midfoot plantar ulcer in Charcot deformity. J Wound Care. 2008;17(2):53-58. doi: https://doi.org/10.12968/jowc.2008.17.2.28178

140. Galli M, Scavone G, Vitiello R, Flex A, Caputo S, Pitocco D. Surgical treatment for chronic Charcot neuroarthropathy. Foot (Edinb). 2018;36:59-66. doi: https://doi.org/10.1016/j.foot.2018.02.001

141. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34-40. doi: https://doi.org/10.1016/s1067-2516(99)80086-6

142. Molines-Barroso RJ, Lázaro-Martínez JL, Beneit-Montesinos JV, et al. Early Foot Structural Changes After Lateral Column Exostectomy in Patients With Charcot Foot. Int J Low Extrem Wounds. 2019;18(2):129-134. doi: https://doi.org/10.1177/1534734619848553

143. Kummen I, Phyo N, Kavarthapu V. Charcot foot reconstruction—how do hardware failure and non-union affect the clinical outcomes? Ann Joint. 2020;5:25. doi: https://doi.org/10.21037/aoj.2020.01.06

144. Richman J, Cota A, Weinfeld S. Intramedullary Nailing and External Ring Fixation for Tibiotalocalcaneal Arthrodesis in Charcot Arthropathy. Foot Ankle Int. 2017;38(2):149-152. doi: https://doi.org/10.1177/1071100716671884

145. Galhoum AE, Trivedi V, Askar M, et al. Management of Ankle Charcot Neuroarthropathy: A Systematic Review. J Clin Med. 2021;10(24):5923. doi: https://doi.org/10.3390/jcm10245923

146. Reinke C, Lotzien S, Yilmaz E, et al. Tibiocalcaneal arthrodesis using the Ilizarov fixator in compromised hosts: an analysis of 19 patients. Arch Orthop Trauma Surg. 2022;142(7):1359-1366. doi: https://doi.org/10.1007/s00402-021-03751-0

147. Rochman R, Jackson Hutson J, Alade O. Tibiocalcaneal arthrodesis using the Ilizarov technique in the presence of bone loss and infection of the talus. Foot Ankle Int. 2008;29(10):1001-1008. doi: https://doi.org/10.3113/FAI.2008.1001

148. Kavarthapu V, Guduri V, Hester T. Combined Charcot hindfoot and midfoot reconstruction using internal fixation methodsurgical technique and single surgeon series. Ann Jt. 2023;8:10. doi: https://doi.org/10.21037/aoj-22-23

149. Caravaggi CM, Sganzaroli AB, Galenda P, et al. Long-term follow-up of tibiocalcaneal arthrodesis in diabetic patients with early chronic Charcot osteoarthropathy. J Foot Ankle Surg. 2012;51(4):408-411. doi: https://doi.org/10.1053/j.jfas.2012.04.007

150. Dalla Paola L, Volpe A, Varotto D, et al. Use of a retrograde nail for ankle arthrodesis in Charcot neuroarthropathy: a limb salvage procedure. Foot Ankle Int. 2007;28(9):967-970. doi: https://doi.org/10.3113/FAI.2007.0967

151. Ersin M, Demirel M, Chodza M, Bilgili F, Kiliçoglu OI. Midterm results of hindfoot arthrodesis with a retrograde intra-medullary nail in 24 patients with diabetic Charcot neuroarthropathy. Acta Orthop. 2020;91(3):336-340. doi: https://doi.org/10.1080/17453674.2020.1746605

152. Siebachmeyer M, Boddu K, Bilal A, et al. Outcome of one-stage correction of deformities of the ankle and hindfoot and fusion in Charcot neuroarthropathy using a retrograde intramedullary hindfoot arthrodesis nail. Bone Joint J. 2015;97-B(1):76-82. doi: https://doi.org/10.1302/0301-620X.97B1.34542

153. La Fontaine J, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot (Edinb). 2016;26:7-14. doi: https://doi.org/10.1016/j.foot.2015.11.001

154. Faglia E, Clerici G, Caminiti M, Curci V, Somalvico F. Influence of osteomyelitis location in the foot of diabetic patients with transtibial amputation. Foot Ankle Int. 2013;34(2):222-227. doi: https://doi.org/10.1177/1071100712467436

155. Winkler E, Schöni M, Krähenbühl N, Uçkay I, Waibel FWA. Foot Osteomyelitis Location and Rates of Primary or Secondary Major Amputations in Patients With Diabetes. Foot Ankle Int. 2022;43(7):957-967. doi: https://doi.org/10.1177/10711007221088552

156. van Netten JJ, Sacco ICN, Lavery L, et al. Clinical and biomechanical effectiveness of foot-ankle exercise programs and weight-bearing activity in people with diabetes and neuropathy: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2024;40(3):e3649. doi: https://doi.org/10.1002/dmrr.3649

157. Sinacore DR, Hastings MK, Bohnert KL, et al. Immobilization-induced osteolysis and recovery in neuropathic foot impairments. Bone. 2017;105:237-244. doi: https://doi.org/10.1016/j.bone.2017.09.009

158. Hastings MK, Sinacore DR, Fielder FA, Johnson JE. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther. 2005;85(3):249-256

159. McGregor PC, Lyons MM, Pinzur MS. Quality of Life Improvement Following Reconstruction of Midtarsal Charcot Foot Deformity: A Five Year Follow-Up. Iowa Orthop J. 2022;42(1):109-112

160. American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S231-S243. doi: https://doi.org/10.2337/dc24-S012

161. Bus SA, Sacco ICN, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3651. doi: https://doi.org/10.1002/dmrr.3651

162. Bus SA, van Deursen RW, Armstrong DG, et al. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32 Suppl 1:99-118. doi: https://doi.org/10.1002/dmrr.2702

163. Bus SA, Waaijman R, Arts M, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care. 2013;36(12):4109-4116. doi: https://doi.org/10.2337/dc13-0996

164. López-Moral M, Lázaro-Martínez JL, García-Morales E, García-Álvarez Y, Álvaro-Afonso FJ, Molines-Barroso RJ. Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of recurrence in patients with diabetes mellitus and diabetic polineuropathy: A randomized clinical trial. PLoS One. 2019;14(7):e0219537. doi: https://doi.org/10.1371/journal.pone.0219537

165. Korst GS, Ratliff HT, Torian J, et al. Delayed Diagnosis of Charcot Foot: A Systematic Review. J Foot Ankle Surg. 2022;61(5):1109-1113. doi: https://doi.org/10.1053/j.jfas.2022.01.008